Novartis is stopping the development of ianalumab in hidradenitis suppurativa (HS) after a Phase IIb proof-of-concept trial ...

As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...

Your immune system is supposed to protect you from viruses, bacteria, and other harmful invaders. However, when you have an ...

Fragile X disorders include two distinct conditions: fragile X syndrome (the most common single-gene cause of developmental ...

A new study published in the Journal of American Medical Association showed that individuals with autoimmune skin diseases ...

Many women with serious underlying medical conditions like heart disease need birth control that won't make their conditions ...